Literature DB >> 20713236

Current epidemiology of Meniere's syndrome.

Thomas H Alexander1, Jeffrey P Harris.   

Abstract

The burden of Ménière syndrome (MS) is substantial, especially when considering the significant impact on the quality of life of those affected. Reported estimates of incidence and prevalence have varied widely due to methodological differences between studies, changes in criteria for diagnosis of MS, and differences in populations studied. Reported prevalence rates for MS range from 3.5 per 100,000 to 513 per 100,000. A recent study using health claims data for more than 60 million patients in the United States found prevalence of 190 per 100,000 with a female:male ratio of 1.89:1. The prevalence of MS increases with increasing age. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20713236     DOI: 10.1016/j.otc.2010.05.001

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  36 in total

Review 1.  [Diagnostic criteria for Menière's disease according to the Classification Committee of the Bárány Society].

Authors:  J A Lopez-Escamez; J Carey; W-H Chung; J A Goebel; M Magnusson; M Mandalà; D E Newman-Toker; M Strupp; M Suzuki; F Trabalzini; A Bisdorff
Journal:  HNO       Date:  2017-11       Impact factor: 1.284

2.  MR volumetric assessment of endolymphatic hydrops.

Authors:  R Gürkov; A Berman; O Dietrich; W Flatz; C Jerin; E Krause; D Keeser; B Ertl-Wagner
Journal:  Eur Radiol       Date:  2014-10-16       Impact factor: 5.315

Review 3. 

Authors:  Vincent Wu; Edward A Sykes; Michael M Beyea; Matthew T W Simpson; Jason A Beyea
Journal:  Can Fam Physician       Date:  2019-07       Impact factor: 3.275

4.  Glucocorticoids stimulate endolymphatic water reabsorption in inner ear through aquaporin 3 regulation.

Authors:  Jérôme Nevoux; Say Viengchareun; Ingrid Lema; Anne-Lise Lecoq; Evelyne Ferrary; Marc Lombès
Journal:  Pflugers Arch       Date:  2014-10-23       Impact factor: 3.657

Review 5.  Approach to Ménière disease management.

Authors:  Vincent Wu; Edward A Sykes; Michael M Beyea; Matthew T W Simpson; Jason A Beyea
Journal:  Can Fam Physician       Date:  2019-07       Impact factor: 3.275

6.  Patient Perceptions of Effectiveness in Treatments for Menière's Disease: a National Survey in Italy.

Authors:  Bryan Ward; Vincent Wettstein; John Golding; Giulia Corallo; Daniele Nuti; Franco Trabalzini; Marco Mandala
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

7.  Publishing Trends in Otology and Neurotology.

Authors:  Ryan Boerner; Jonathan L Hatch; Elizabeth Harruff; Shaun A Nguyen; Habib G Rizk; Ted A Meyer; Paul R Lambert; Theodore R McRackan
Journal:  Otol Neurotol       Date:  2018-01       Impact factor: 2.311

8.  Identification of two novel mutations in FAM136A and DTNA genes in autosomal-dominant familial Meniere's disease.

Authors:  Teresa Requena; Sonia Cabrera; Carmen Martín-Sierra; Steven D Price; Anna Lysakowski; José A Lopez-Escamez
Journal:  Hum Mol Genet       Date:  2014-10-09       Impact factor: 6.150

9.  Intratympanic (IT) Therapies for Menière's Disease: Some Consensus Among the Confusion.

Authors:  Desi P Schoo; Grace X Tan; Matthew R Ehrenburg; Seth E Pross; Bryan K Ward; John P Carey
Journal:  Curr Otorhinolaryngol Rep       Date:  2017-05-03

Review 10.  Effects of intratympanic gentamicin and intratympanic glucocorticoids in Ménière's disease: a network meta-analysis.

Authors:  Weiming Hao; Huiqian Yu; Huawei Li
Journal:  J Neurol       Date:  2021-01-02       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.